340
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Are You Game – Theoretically? A Critical Discussion of A Game-theory-based Argument in Favour of Banning Doping

References

  • BAILEY, D.M., P. ROBACH, J.J. THOMSEN, and C. LUNDBY. 2006. Erythropoietin depletes iron stores: Antioxidant neuroprotection for ischemic stroke? Stroke 37(10): 2453–2453. doi:10.1161/01.STR.0000239787.92203.16
  • BOSTROM, N. and R. ROACHE. 2008. Ethical issues in human enhancement. In New Waves in Applied Ethics, edited by J. Ryber, T.S. Petersen, and C. Wolf. Basingstoke: Palgrave Macmillan: 120–52.
  • BREITSAMETER, C. 2017. How to justify a ban on doping? Journal of Medical Ethics 43(5): 287–92. doi:10.1136/medethics-2015-103091
  • BREIVIK, G. 1987. The doping dilemma. Sportwissenschaft 17: 83–94.
  • BROWN, W.M. 1984. Paternalism, drugs, and the nature of sports. Journal of the Philosophy of Sport 11(1): 14–22. doi:10.1080/00948705.1984.9714409
  • BROWN, W.M. 2001. As American as gatorade and apple pie: Performance drugs and sports. In Ethics in Sport, edited by W.J. Morgan, K.V. Meier, A.J. Schneider, and I.L. Champaign. United States: Human Kinetics: 142–68.
  • CHOMIAK, J., A. JUNGE, L. PETERSON, and J. DVORAK. 2016. Severe Injuries in Football Players. The American Journal of Sports Medicine 44: 309–17. doi:10.1177/28.suppl_5.s-58
  • CHWANG, E. 2012. Why athletic doping should be banned. Journal of Applied Philosophy 29(1): 33–49. doi:10.1111/j.1468-5930.2011.00547.x
  • COYLE, D. 2005. Lance Armstrong: Tour de force. Tough guys, flawed heroes and one man’s battle for ultimate supremacy. UK: CollinsWillow.
  • DAUMANN, F. 2018. Doping in high-performance sport: The economic perspective. In The Palgrave handbook on the economics of manipulation in sport, edited by M. Breuer and D. Forrest. Cham: Palgrave Macmillan: 71–90.
  • DIMEO, P. and V. MØLLER. 2018. The anti-doping crisis in sport: Causes, consequences, solutions. Abingdon (UK) and New York (USA): Routledge.
  • JOHNSON, M. 2016. Spitting in the soup: Inside the dirty game of doping in sports. Boulder, Colorado, USA: VeloPress.
  • LAVAZZA, A. 2019. Transcranial electrical stimulation for human enhancement and the risk of inequality: Prohibition or compensation? Bioethics 33(1): 122–31. doi:10.1111/bioe.12504
  • LUNDBY, C. and N.V. OLSEN. 2011. Effects of recombinant human erythropoietin in normal humans. The Journal of Physiology 589(6): 1265–71. doi:10.1113/jphysiol.2010.195917
  • MCNAMEE, M.J. 2015. The spirit of sport and the world anti-doping code. In Routledge handbook of drugs and sport, edited by V. Møller, I. Waddington, and J.M. Hoberman. London: Routledge: 41–53.
  • MØLLER, V. 2010. The ethics of doping and anti-doping. London: Routledge.
  • MOORE, E. 2017. Did Armstrong cheat? Sport, Ethics and Philosophy 11(4): 413–27. doi:10.1080/17511321.2017.1292306
  • NINOT, G., P. CONNES, and C. CAILLAUD. 2006. Effects of recombinant human erythropoietin injections on physical self in endurance athletes. Journal of Sports Sciences 24(4): 383–91. doi:10.1080/02640410500131340
  • NOZICK, R. 1969. Coercion. In Philosophy, science, and method: Essays in honor of Ernest Nagel, edited by S. Morgenbesser, P. Suppes, M. White, and N.Y. New York. St Martin’s Press: 440–72.
  • PAOLI, L. and A. Donati. 2013. The sports doping market: Understanding supply and demand, and the challenges of their control. Berlin, Germany: Springer Science & Business Media.
  • PETERSEN, T.S. and K. LIPPERT-RASMUSSEN. 2021. Doping, fairness, and unequal responsiveness: A response to Lavazza. Bioethics 35: 714–17. Online first:. doi:10.1111/bioe.12908
  • PETERSEN, T.S. 2021. Doping in sport: A defence. Abingdon (UK) and New York (USA): Routledge.
  • PITSCH, W. and E. EMRICH. 2012. The frequency of doping in elite sport: Results of a replication study. International Review for the Sociology of Sport 47(5): 559–80. doi:10.1177/1012690211413969
  • RUSSELL, J.S. and A. BROWNE. 2018. Performance-enhancing drugs as a collective action problem. Journal of the Philosophy of Sport 45(2): 109–27. doi:10.1080/00948705.2018.1440355
  • SAVULESCU, J. 2015. Healthy doping: Why we should legalise performance-enhancing drugs in sport. In Routledge handbook of drugs and sport, edited by V. Møller, I. Waddington, and J.M. Hoberman (pp. 350–362). London: Routledge.
  • SCHNEIDER, A.J. and R.B. Butcher. 2002. A philosophical overview of the arguments on banning doping in sport. In Values in Sport, edited by C. Tamburrini, and T. Tännsjö (pp.195–209). Oxfordshire (UK): Routledge.
  • SIMON, R.L. 1984. Good competition and drug-enhanced performance. Journal of the Philosophy of Sport 11(1): 6–13. doi:10.1080/00948705.1984.9714408
  • TAMBURRINI, C. 2002. What’s wrong with doping? In Values in Sport, edited by C. Tamburrini, and T. Tännsjö. Abingdon (UK) and New York (USA): Routledge: 210–26.
  • ULRICH, R., H.G. POPE, L. CLÉRET, A. PETRÓCZI, T. NEPUSZ, J. SCHAFFER, and P. SIMON. 2018. Doping in two elite athletics competitions assessed by randomized-response surveys. Sports Medicine 48(1): 211–19. doi:10.1007/s40279-017-0765-4
  • VAN AMSTERDAM, J., A. OPPERHUIZEN, and F. HARTGENS. 2010. Adverse health effects of anabolic-androgenic steroids. Regulatory Toxicology and Pharmacology 57(1): 117–23. doi:10.1016/j.yrtph.2010.02.001
  • VEBER, M. 2014. The coercion argument against performance-enhancing drugs. Journal of the Philosophy of Sport 41(2): 267–77. doi:10.1080/00948705.2013.832264
  • WADA (World Anti-Doping Agency). 2020. Dangers of doping: Get the facts. https://www.wada-ama.org/sites/default/files/resources/files/WADA_Dangers_of_Doping_EN.pdf
  • WADA. 2021. Prohibited list. Accessed 2021.https://www.wada-ama.org/en/resources/science-medicine/prohibited-list-documents Accessed 14 January 2022
  • WALDÉN, M., M. HÄGGLUND, and J. EKSTRAND. 2005. UEFA Champions League study: A prospective study of injuries in professional football during the 2001–2002 season. British Journal of Sports Medicine 39(8): 542–46. doi:10.1136/bjsm.2004.014571

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.